146 related articles for article (PubMed ID: 10465268)
21. The src homology 2 and phosphotyrosine binding domains of the ShcC adaptor protein function as inhibitors of mitogenic signaling by the epidermal growth factor receptor.
O'Bryan JP; Lambert QT; Der CJ
J Biol Chem; 1998 Aug; 273(32):20431-7. PubMed ID: 9685397
[TBL] [Abstract][Full Text] [Related]
22. Repair by Src kinase of function-impaired RET with multiple endocrine neoplasia type 2A mutation with substitutions of tyrosines in the COOH-terminal kinase domain for phenylalanine.
Kato M; Takeda K; Kawamoto Y; Iwashita T; Akhand AA; Senga T; Yamamoto M; Sobue G; Hamaguchi M; Takahashi M; Nakashima I
Cancer Res; 2002 Apr; 62(8):2414-22. PubMed ID: 11956105
[TBL] [Abstract][Full Text] [Related]
23. Engineering the recruitment of phosphotyrosine binding domain-containing adaptor proteins reveals distinct roles for RET receptor-mediated cell survival.
Lundgren TK; Scott RP; Smith M; Pawson T; Ernfors P
J Biol Chem; 2006 Oct; 281(40):29886-96. PubMed ID: 16847065
[TBL] [Abstract][Full Text] [Related]
24. Shc phosphotyrosine-binding domain dominantly interacts with epidermal growth factor receptors and mediates Ras activation in intact cells.
Sakaguchi K; Okabayashi Y; Kido Y; Kimura S; Matsumura Y; Inushima K; Kasuga M
Mol Endocrinol; 1998 Apr; 12(4):536-43. PubMed ID: 9544989
[TBL] [Abstract][Full Text] [Related]
25. The oncogenic versions of the Ret and Trk tyrosine kinases bind Shc and Grb2 adaptor proteins.
Borrello MG; Pelicci G; Arighi E; De Filippis L; Greco A; Bongarzone I; Rizzetti M; Pelicci PG; Pierotti MA
Oncogene; 1994 Jun; 9(6):1661-8. PubMed ID: 8183561
[TBL] [Abstract][Full Text] [Related]
26. Discrimination between phosphotyrosine-mediated signaling properties of conventional and neuronal Shc adapter molecules.
Nakamura T; Komiya M; Gotoh N; Koizumi S; Shibuya M; Mori N
Oncogene; 2002 Jan; 21(1):22-31. PubMed ID: 11791173
[TBL] [Abstract][Full Text] [Related]
27. Interaction with the phosphotyrosine binding domain/phosphotyrosine interacting domain of SHC is required for the transforming activity of the FLT4/VEGFR3 receptor tyrosine kinase.
Fournier E; Rosnet O; Marchetto S; Turck CW; Rottapel R; Pelicci PG; Birnbaum D; Borg JP
J Biol Chem; 1996 May; 271(22):12956-63. PubMed ID: 8662748
[TBL] [Abstract][Full Text] [Related]
28. The role of the Shc phosphotyrosine interaction/phosphotyrosine binding domain and tyrosine phosphorylation sites in polyoma middle T antigen-mediated cell transformation.
Blaikie PA; Fournier E; Dilworth SM; Birnbaum D; Borg JP; Margolis B
J Biol Chem; 1997 Aug; 272(33):20671-7. PubMed ID: 9252386
[TBL] [Abstract][Full Text] [Related]
29. Phosphotyrosine-independent binding of SHC to the NPLH sequence of murine protein-tyrosine phosphatase-PEST. Evidence for extended phosphotyrosine binding/phosphotyrosine interaction domain recognition specificity.
Charest A; Wagner J; Jacob S; McGlade CJ; Tremblay ML
J Biol Chem; 1996 Apr; 271(14):8424-9. PubMed ID: 8626541
[TBL] [Abstract][Full Text] [Related]
30. N-Shc and Sck, two neuronally expressed Shc adapter homologs. Their differential regional expression in the brain and roles in neurotrophin and Src signaling.
Nakamura T; Muraoka S; Sanokawa R; Mori N
J Biol Chem; 1998 Mar; 273(12):6960-7. PubMed ID: 9507002
[TBL] [Abstract][Full Text] [Related]
31. A mammalian adaptor protein with conserved Src homology 2 and phosphotyrosine-binding domains is related to Shc and is specifically expressed in the brain.
O'Bryan JP; Songyang Z; Cantley L; Der CJ; Pawson T
Proc Natl Acad Sci U S A; 1996 Apr; 93(7):2729-34. PubMed ID: 8610109
[TBL] [Abstract][Full Text] [Related]
32. Tyrosine phosphorylation-dependent and -independent role of Shc in the regulation of IGF-1-induced mitogenesis and glycogen synthesis.
Sasaoka T; Ishiki M; Wada T; Hori H; Hirai H; Haruta T; Ishihara H; Kobayashi M
Endocrinology; 2001 Dec; 142(12):5226-35. PubMed ID: 11713219
[TBL] [Abstract][Full Text] [Related]
33. The insulin receptor substrate (IRS)-1 recruits phosphatidylinositol 3-kinase to Ret: evidence for a competition between Shc and IRS-1 for the binding to Ret.
Melillo RM; Carlomagno F; De Vita G; Formisano P; Vecchio G; Fusco A; Billaud M; Santoro M
Oncogene; 2001 Jan; 20(2):209-18. PubMed ID: 11313948
[TBL] [Abstract][Full Text] [Related]
34. Characterization of the phosphotyrosine-binding domain of the Drosophila Shc protein.
Li SC; Lai KM; Gish GD; Parris WE; van der Geer P; Forman-Kay J; Pawson T
J Biol Chem; 1996 Dec; 271(50):31855-62. PubMed ID: 8943228
[TBL] [Abstract][Full Text] [Related]
35. p150Ship, a signal transduction molecule with inositol polyphosphate-5-phosphatase activity.
Lioubin MN; Algate PA; Tsai S; Carlberg K; Aebersold A; Rohrschneider LR
Genes Dev; 1996 May; 10(9):1084-95. PubMed ID: 8654924
[TBL] [Abstract][Full Text] [Related]
36. Structural basis for the specific recognition of RET by the Dok1 phosphotyrosine binding domain.
Shi N; Ye S; Bartlam M; Yang M; Wu J; Liu Y; Sun F; Han X; Peng X; Qiang B; Yuan J; Rao Z
J Biol Chem; 2004 Feb; 279(6):4962-9. PubMed ID: 14607833
[TBL] [Abstract][Full Text] [Related]
37. Differential requirement of Tyr1062 multidocking site by RET isoforms to promote neural cell scattering and epithelial cell branching.
Degl'Innocenti D; Arighi E; Popsueva A; Sangregorio R; Alberti L; Rizzetti MG; Ferrario C; Sariola H; Pierotti MA; Borrello MG
Oncogene; 2004 Sep; 23(44):7297-309. PubMed ID: 15326489
[TBL] [Abstract][Full Text] [Related]
38. Shc products are substrates of erbB-2 kinase.
Segatto O; Pelicci G; Giuli S; Digiesi G; Di Fiore PP; McGlade J; Pawson T; Pelicci PG
Oncogene; 1993 Aug; 8(8):2105-12. PubMed ID: 8101647
[TBL] [Abstract][Full Text] [Related]
39. Identification of residues within the SHC phosphotyrosine binding/phosphotyrosine interaction domain crucial for phosphopeptide interaction.
Yajnik V; Blaikie P; Bork P; Margolis B
J Biol Chem; 1996 Jan; 271(4):1813-6. PubMed ID: 8567619
[TBL] [Abstract][Full Text] [Related]
40. Structure and ligand recognition of the phosphotyrosine binding domain of Shc.
Zhou MM; Ravichandran KS; Olejniczak EF; Petros AM; Meadows RP; Sattler M; Harlan JE; Wade WS; Burakoff SJ; Fesik SW
Nature; 1995 Dec; 378(6557):584-92. PubMed ID: 8524391
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]